These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26237606)

  • 1. Opportunities and Limitations of Modelling Alzheimer's Disease with Induced Pluripotent Stem Cells.
    Ovchinnikov DA; Wolvetang EJ
    J Clin Med; 2014 Dec; 3(4):1357-72. PubMed ID: 26237606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases.
    Machairaki V
    Adv Exp Med Biol; 2020; 1195():93-94. PubMed ID: 32468463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease.
    Wu YY; Chiu FL; Yeh CS; Kuo HC
    Open Biol; 2019 Jan; 9(1):180177. PubMed ID: 30958120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling mitochondrial dysfunction in Alzheimer's disease using human induced pluripotent stem cells.
    Hawkins KE; Duchen M
    World J Stem Cells; 2019 May; 11(5):236-253. PubMed ID: 31171953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced Pluripotent Stem Cell-Derived Astroglia: A New Tool for Research Towards the Treatment of Alzheimer's Disease.
    Atkinson-Dell R; Mohamet L
    Adv Exp Med Biol; 2019; 1175():383-405. PubMed ID: 31583596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stepping back to move forward: a current review of iPSCs in the fight against Alzheimer's disease.
    Devineni A; Tohme S; Kody MT; Cowley RA; Harris BT
    Am J Stem Cells; 2016; 5(3):99-106. PubMed ID: 27853631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Use of Patient-Derived Induced Pluripotent Stem Cells for Alzheimer's Disease Modeling.
    Lee C; Willerth SM; Nygaard HB
    Prog Neurobiol; 2020 Sep; 192():101804. PubMed ID: 32464173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer's disease.
    Marei HE; Khan MUA; Hasan A
    Cell Mol Biol Lett; 2023 Nov; 28(1):98. PubMed ID: 38031028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-derived iPSCs, a reliable
    Amponsah AE; Guo R; Kong D; Feng B; He J; Zhang W; Liu X; Du X; Ma Z; Liu B; Ma J; Cui H
    Rev Neurosci; 2021 Jun; 32(4):379-402. PubMed ID: 33550785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Induced Pluripotent Stem Cells and the Modelling of Alzheimer's Disease: The Human Brain Outside the Dish.
    Tong G; Izquierdo P; Raashid RA
    Open Neurol J; 2017; 11():27-38. PubMed ID: 29151989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human stem cell transplantation models of Alzheimer's disease.
    Ifediora N; Canoll P; Hargus G
    Front Aging Neurosci; 2024; 16():1354164. PubMed ID: 38450383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks.
    Hossini AM; Megges M; Prigione A; Lichtner B; Toliat MR; Wruck W; Schröter F; Nuernberg P; Kroll H; Makrantonaki E; Zouboulis CC; Adjaye J
    BMC Genomics; 2015 Feb; 16(1):84. PubMed ID: 25765079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased susceptibility to Aβ toxicity in neuronal cultures derived from familial Alzheimer's disease (PSEN1-A246E) induced pluripotent stem cells.
    Armijo E; Gonzalez C; Shahnawaz M; Flores A; Davis B; Soto C
    Neurosci Lett; 2017 Feb; 639():74-81. PubMed ID: 28034781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human-induced pluripotent stem cells as a model for studying sporadic Alzheimer's disease.
    Riemens RJM; Kenis G; van den Beucken T
    Neurobiol Learn Mem; 2020 Nov; 175():107318. PubMed ID: 32977028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capturing Alzheimer's disease genomes with induced pluripotent stem cells: prospects and challenges.
    Israel MA; Goldstein LS
    Genome Med; 2011 Jul; 3(7):49. PubMed ID: 21867573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human-Induced Pluripotent Stem Cell (hiPSC)-Derived Neurons and Glia for the Elucidation of Pathogenic Mechanisms in Alzheimer's Disease.
    Young JE; Goldstein LSB
    Methods Mol Biol; 2023; 2561():105-133. PubMed ID: 36399267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Advances and Limitations in Modeling ALS/FTD in a Dish Using Induced Pluripotent Stem Cells.
    Guo W; Fumagalli L; Prior R; Van Den Bosch L
    Front Neurosci; 2017; 11():671. PubMed ID: 29326542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced Pluripotent Stem Cells in Drug Discovery and Neurodegenerative Disease Modelling.
    Beghini DG; Kasai-Brunswick TH; Henriques-Pons A
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.